This first-of-its-kind fund is focused on investing in innovative health care products, services, and technologies designed to address critical areas of cardiovascular care. Dr. Joon Sup Lee, co-director of the UPMC Heart and Vascular Institute (HVI), expects that technology startups focused on such areas as prevention and patient education will be part of the fund’s investments, while capital-intensive drugs and devices will not. Cardeation Capital “is really another opportunity to fill some of the gaps in cardiovascular care,” he says.
“As one of the largest integrated health systems in the United States, UPMC is making significant investments in the disruptive technologies needed to dramatically improve the quality and effectiveness of healthcare,” says Tal Heppenstall, president of UPMC Enterprises. “We expect that Cardeation Capital, working closely with our world-renowned clinicians at HVI, will play a critical role in this strategy for the benefit of our patients.”
A Year in Review: A comprehensive look at UPMC Enterprises 2020
Over the last year, UPMC Enterprises, our portfolio companies, and select partners have all supported UPMC’s mission of Life Changing Medicine. In the booklet below, we have compiled highlights from a truly unique year and recognize the team members and projects that have enabled our success.
Writing a Fully Unit Testable Android App: The journey begins at the start of your project
Even as recently as API 30, the platform continues to evolve in this unfortunate direction, …
Machine Learning and Structural Bias in Health Care
In November 2020, the Center for Connected Medicine (CCM) convened a group of experts in …